Free Trial

VSee Health (VSEE) Competitors

VSee Health logo
$1.21 -0.08 (-6.20%)
Closing price 08/1/2025 04:00 PM Eastern
Extended Trading
$1.33 +0.12 (+9.92%)
As of 08/1/2025 07:09 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

VSEE vs. BRTX, SSY, MGRX, BGLC, DHAC, ACON, ATIP, OTRK, NIVF, and OPGN

Should you be buying VSee Health stock or one of its competitors? The main competitors of VSee Health include Biorestorative Therapies (BRTX), SunLink Health Systems (SSY), Mangoceuticals (MGRX), BioNexus Gene Lab (BGLC), Digital Health Acquisition (DHAC), Aclarion (ACON), ATI Physical Therapy (ATIP), Ontrak (OTRK), NewGenIvf Group (NIVF), and OpGen (OPGN). These companies are all part of the "healthcare" industry.

VSee Health vs. Its Competitors

Biorestorative Therapies (NASDAQ:BRTX) and VSee Health (NASDAQ:VSEE) are both healthcare companies, but which is the superior investment? We will compare the two companies based on the strength of their risk, institutional ownership, valuation, earnings, analyst recommendations, media sentiment, dividends and profitability.

VSee Health has lower revenue, but higher earnings than Biorestorative Therapies.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Biorestorative Therapies$400K26.44-$8.98M-$1.47-0.96
VSee HealthN/AN/A-$4.41MN/AN/A

VSee Health has a net margin of 0.00% compared to Biorestorative Therapies' net margin of -3,093.61%. VSee Health's return on equity of 0.00% beat Biorestorative Therapies' return on equity.

Company Net Margins Return on Equity Return on Assets
Biorestorative Therapies-3,093.61% -129.47% -86.02%
VSee Health N/A N/A N/A

69.4% of Biorestorative Therapies shares are held by institutional investors. Comparatively, 1.0% of VSee Health shares are held by institutional investors. 25.5% of Biorestorative Therapies shares are held by insiders. Comparatively, 6.6% of VSee Health shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

In the previous week, Biorestorative Therapies' average media sentiment score of 0.00 equaled VSee Health'saverage media sentiment score.

Company Overall Sentiment
Biorestorative Therapies Neutral
VSee Health Neutral

Biorestorative Therapies presently has a consensus target price of $18.00, suggesting a potential upside of 1,176.60%. VSee Health has a consensus target price of $5.00, suggesting a potential upside of 313.22%. Given Biorestorative Therapies' higher probable upside, research analysts plainly believe Biorestorative Therapies is more favorable than VSee Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Biorestorative Therapies
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00
VSee Health
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
1 Strong Buy rating(s)
4.00

Summary

VSee Health beats Biorestorative Therapies on 6 of the 11 factors compared between the two stocks.

Get VSee Health News Delivered to You Automatically

Sign up to receive the latest news and ratings for VSEE and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding VSEE and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

VSEE vs. The Competition

MetricVSee HealthINTERNET SOFTWARE IndustryComputer SectorNASDAQ Exchange
Market CapN/A$19.20B$29.01B$9.53B
Dividend YieldN/A2.95%3.08%4.09%
P/E RatioN/A85.9248.1723.83
Price / SalesN/A154.471,544.4766.13
Price / CashN/A92.4138.0757.96
Price / Book-0.368.088.435.54
Net Income-$4.41M$341.62M$782.80M$259.28M
7 Day Performance-9.02%-6.56%3.32%-4.67%
1 Month Performance1.68%0.43%-0.17%4.38%
1 Year Performance-71.53%56.28%52,721.68%17.90%

VSee Health Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
VSEE
VSee Health
1.3579 of 5 stars
$1.21
-6.2%
$5.00
+313.2%
-50.2%$0.00N/A0.00N/AGap Down
High Trading Volume
BRTX
Biorestorative Therapies
3.5123 of 5 stars
$1.53
-2.5%
$18.00
+1,076.5%
-7.8%$11.48M$400K-1.047
SSY
SunLink Health Systems
1.7256 of 5 stars
$1.24
-6.1%
N/A+22.4%$8.73M$31.09M8.861,376Gap Up
MGRX
Mangoceuticals
N/A$1.63
-4.7%
N/A-98.0%$8.43M$620K-0.353Positive News
BGLC
BioNexus Gene Lab
0.2218 of 5 stars
$4.46
-2.0%
N/A+43.2%$8.02M$9.27M0.0030News Coverage
Short Interest ↑
Gap Down
DHAC
Digital Health Acquisition
N/A$1.33
-2.2%
N/A-43.8%$4.79MN/A0.002,021Gap Up
ACON
Aclarion
1.4849 of 5 stars
$7.71
-1.7%
$11,758.50
+152,409.7%
-99.7%$4.47M$50K0.007Positive News
ATIP
ATI Physical Therapy
0.1268 of 5 stars
$0.68
+87.5%
N/A-89.1%$2.98M$741.86M-0.045,600News Coverage
Gap Up
OTRK
Ontrak
2.1365 of 5 stars
$0.49
-6.9%
$24.00
+4,800.0%
-92.0%$2.07M$10.85M-0.03250Upcoming Earnings
Short Interest ↑
NIVF
NewGenIvf Group
N/A$0.46
-11.6%
N/A-99.8%$1.99M$5.43M0.00N/APositive News
Gap Up
High Trading Volume
OPGN
OpGen
N/A$0.04
flat
N/A-98.7%$396K$2.67M0.00100Positive News
Short Interest ↓

Related Companies and Tools


This page (NASDAQ:VSEE) was last updated on 8/2/2025 by MarketBeat.com Staff
From Our Partners